Pivotal Trial Toward Effectiveness of Self-administered OCT in Neovascular Age-related Macular Degeneration. Report 2-Artificial Intelligence Analytics.

IF 3.2 Q1 OPHTHALMOLOGY Ophthalmology science Pub Date : 2024-11-26 eCollection Date: 2025-03-01 DOI:10.1016/j.xops.2024.100662
Eric W Schneider, Jeffrey S Heier, Nancy M Holekamp, Miguel A Busquets, Alan L Wagner, S Krishna Mukkamala, Christopher D Riemann, Seong Y Lee, Brian C Joondeph, Steven S Houston, Kester Nahen, Nishant Mohan, Gidi Benyamini
{"title":"Pivotal Trial Toward Effectiveness of Self-administered OCT in Neovascular Age-related Macular Degeneration. Report 2-Artificial Intelligence Analytics.","authors":"Eric W Schneider, Jeffrey S Heier, Nancy M Holekamp, Miguel A Busquets, Alan L Wagner, S Krishna Mukkamala, Christopher D Riemann, Seong Y Lee, Brian C Joondeph, Steven S Houston, Kester Nahen, Nishant Mohan, Gidi Benyamini","doi":"10.1016/j.xops.2024.100662","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To validate the performance of the Notal OCT Analyzer (NOA) in processing self-administered OCT images from an OCT system designed for home use (home OCT [HOCT]) as part of a pivotal study aimed at achieving de novo United States Food and Drug Admininstration marketing authorization.</p><p><strong>Design: </strong>A prospective quantitative cross-sectional artificial intelligence study.</p><p><strong>Participants: </strong>The study enrolled adults aged ≥55 years diagnosed with neovascular age-related macular degeneration (nAMD) in ≥1 eligible eye with a best-corrected visual acuity of 20/320 or better.</p><p><strong>Methods: </strong>Participants self-imaged 4 times on each of 2 HOCT devices and once with an in-office OCT (IO-OCT) device during a single visit. Scans were segmented by the NOA and human graders at a certified reading center (RC).</p><p><strong>Main outcome measures: </strong>Intradevice and interdevice repeatability and reproducibility of total retinal hyporeflective (TRO) volume estimation by the NOA on HOCT-acquired images as compared with that of RC graders on IO-OCT-acquired images. Additionally, to assess the performance of the NOA in segmentation of TRO over multiple B-scans as compared with RC graders.</p><p><strong>Results: </strong>Self-imaging was performed successfully by 387 participants in 2451 of 2616 attempts (93.7%). For repeatability, the coefficient of variance for NOA was 11.1% for eyes with >10 volume units of TRO imaged with HOCT compared with 16.4% for RC graders segmenting IO-OCT images. The median DICE similarity coefficients for segmentation of TRO by NOA vs. Grader 1, Grader 2, and Grader 3; Grader 1 vs. Grader 2 and Grader 3; and Grader 2 vs. Grader 3 were 0.68, 0.68, 0.61, 0.72, 0.63, 0.70, respectively.</p><p><strong>Conclusions: </strong>The performance of NOA supports the intended use of the system as a tool to monitor TRO at home between routine clinical visits in support of the management of nAMD.</p><p><strong>Financial disclosures: </strong>Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.</p>","PeriodicalId":74363,"journal":{"name":"Ophthalmology science","volume":"5 2","pages":"100662"},"PeriodicalIF":3.2000,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11731483/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmology science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.xops.2024.100662","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To validate the performance of the Notal OCT Analyzer (NOA) in processing self-administered OCT images from an OCT system designed for home use (home OCT [HOCT]) as part of a pivotal study aimed at achieving de novo United States Food and Drug Admininstration marketing authorization.

Design: A prospective quantitative cross-sectional artificial intelligence study.

Participants: The study enrolled adults aged ≥55 years diagnosed with neovascular age-related macular degeneration (nAMD) in ≥1 eligible eye with a best-corrected visual acuity of 20/320 or better.

Methods: Participants self-imaged 4 times on each of 2 HOCT devices and once with an in-office OCT (IO-OCT) device during a single visit. Scans were segmented by the NOA and human graders at a certified reading center (RC).

Main outcome measures: Intradevice and interdevice repeatability and reproducibility of total retinal hyporeflective (TRO) volume estimation by the NOA on HOCT-acquired images as compared with that of RC graders on IO-OCT-acquired images. Additionally, to assess the performance of the NOA in segmentation of TRO over multiple B-scans as compared with RC graders.

Results: Self-imaging was performed successfully by 387 participants in 2451 of 2616 attempts (93.7%). For repeatability, the coefficient of variance for NOA was 11.1% for eyes with >10 volume units of TRO imaged with HOCT compared with 16.4% for RC graders segmenting IO-OCT images. The median DICE similarity coefficients for segmentation of TRO by NOA vs. Grader 1, Grader 2, and Grader 3; Grader 1 vs. Grader 2 and Grader 3; and Grader 2 vs. Grader 3 were 0.68, 0.68, 0.61, 0.72, 0.63, 0.70, respectively.

Conclusions: The performance of NOA supports the intended use of the system as a tool to monitor TRO at home between routine clinical visits in support of the management of nAMD.

Financial disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
自我给药OCT治疗新生血管性年龄相关性黄斑变性疗效的关键试验。报告2:人工智能分析。
目的:验证Notal OCT分析仪(NOA)处理家用OCT系统(家用OCT [HOCT])自给OCT图像的性能,这是一项旨在获得美国食品和药物管理局(fda)重新上市许可的关键研究的一部分。设计:一项前瞻性定量横断面人工智能研究。参与者:该研究招募年龄≥55岁的成年人,诊断为新生血管性年龄相关性黄斑变性(nAMD),≥1只符合条件的眼睛,最佳矫正视力为20/320或更高。方法:参与者在单次就诊期间分别在2台HOCT设备上自行成像4次,在办公室OCT (IO-OCT)设备上自行成像1次。扫描结果由NOA和经认证的阅读中心(RC)的评分员进行分割。主要观察指标:与RC分级器在io - oct图像上的评分相比,NOA在hoct获取图像上的视网膜总低反射(TRO)体积估计在设备内和设备间的可重复性和再现性。此外,与RC分级仪相比,评估NOA在多次b扫描中分割TRO的性能。结果:在2616次尝试中,有2451次(93.7%)的387名参与者成功完成了自我成像。为了可重复性,对于使用HOCT成像的具有bbb10容积单位TRO的眼睛,NOA的方差系数为11.1%,而对于使用RC分级器分割IO-OCT图像的眼睛,NOA的方差系数为16.4%。NOA与分级1、分级2和分级3分割TRO的中位数DICE相似系数1年级与2年级和3年级;2级与3级分别为0.68、0.68、0.61、0.72、0.63、0.70。结论:NOA的表现支持了该系统作为常规临床就诊期间家中TRO监测工具的预期用途,以支持nAMD的管理。财务披露:专有或商业披露可在本文末尾的脚注和披露中找到。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Ophthalmology science
Ophthalmology science Ophthalmology
CiteScore
3.40
自引率
0.00%
发文量
0
审稿时长
89 days
期刊最新文献
Reply. Corrigendum. Associations of Retinal Microvascular Density and Fractal Dimension with Glaucoma: A Prospective Study from UK Biobank. Pivotal Trial Toward Effectiveness of Self-administered OCT in Neovascular Age-related Macular Degeneration. Report 2-Artificial Intelligence Analytics. Population Pharmacokinetics of Pegcetacoplan in Patients with Geographic Atrophy or Neovascular Age-related Macular Degeneration.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1